Serum adiponectin is associated with homocysteine in elderly men and women, and with 5,10-methylenetetrahydrofolate reductase (MTHFR) in a sex-dependent manner

Metabolism: Clinical and Experimental

Volumn 59, Issue 12, 2010, Pages 1767-1774

  Dankner, Rachel ^a,b   Chetrit, Angela ^a   Murad, Havi ^a   Sela, Ben Ami ^a,b   Frystyk, Jan ^c   Raz, Itamar ^d   Flyvbjerg, Allan ^c  

^a Sheba Medical Center   (Ireland)

^b TEL AVIV UNIVERSITY   (Israel)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADIPONECTIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVOR; WAIST CIRCUMFERENCE;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADIPONECTIN; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; SEX FACTORS;

EID: 78549273983     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.05.001     Document Type: Article

References (53)

1. Lihn A.S., Pedersen S.B., and Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity Obes Rev 6 2005 13 21
2. Koh S.B., Park J.K., and Yoon J.H. A serious link between adiponectin levels and metabolic syndrome in a Korean nondiabetic population Metabol 2009 10.1016/i
3. Ouchi N., Ohishi M., and Kihara S. Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 2003 231 234
4. Shimabukuro M., Higa N., and Asahi T. Hypoadiponectinemia is closely linked to endothelial dysfunction in man J Clin Endocrinol Metab 88 2003 3236 3240
5. Fernandez-Real J.M., Castro A., and Vazquez G. Adiponectin is associated with vascular function independent of insulin sensitivity Diabetes Care 27 2004 739 745
6. Kumada M., Kihara S., and Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89
7. Pischon T., Girman C.J., and Hotamisligil G.S. Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
8. Frystyk J., Berne C., and Berglund L. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men J Clin Endo Metab 92 2007 571 576
9. Sattar N., Wannamethee G., and Sarwar N. Adiponectin and coronary heart disease: a prospective study and meta-analysis Circulation 114 2006 623 629
10. Lawlor D.A., Ebrahim S., and Whinoup P. Sex differences in body fat distribution and carotid intima media thickness: cross sectional survey using data from the British regional heart study Journal of Epidemiol and Community Health 58 2004 700 704
11. Sattar N., Watt P., and Cherry L. High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study J Clin Endocrinol Metab 93 2008 1846 1849
12. Kistorp C., Faber J., and Galatius S. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762
13. Pilz S., Mangge H., and Welinitz B. Adiponectin and mortality in patients undergoing coronary angiography J Clin Endocrinol Metab 91 2006 4277 4286
14. Maiolino G., Cesari M., and Sticchi D. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients J Clin Endocrinol Metab 93 2008 3333 3340
15. Wannamethee S.G., Whincup P.H., and Lennon L. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure Arch Intern Med 167 2007 1510 1517
16. Kizer J.R., Barzilay J.I., and Kuller L.H. Adiponectin and risk of coronary heart disease in older men and women J Clin Endocrinol Metab 93 2008 3357 3364
17. Laughlin G.A., Barrett-Connor E., and May S. Association of adiponectin with coronary heart disease and mortality. The Rancho Bernardo study American Journal of Epidemiology. 165 2007 164 174 (Pubitemid 46096378)
18. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 2002 2015 2022
19. Faria-Neto J.R., Chagas A.C., and Bydlowski S.P. Hyperhomocysteinemia in patients with coronary artery disease Braz J Med Biol Res 39 2006 455 463
20. Zee R.Y., Mora S., and Cheng S. Homocysteine, 5,10- methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24 968 initially healthy women Clin Chem 53 2007 845 851
21. Kang S.S., Wong P.W., and Bock H.G. Intermediate hyperhomocysteinemia resulting from compound-549 heterozygosity of methylenetetrahydrofolate reductase-550 mutations Am J Hum Genet 48 1991 546 551
22. Brattstrom L., Wilcken D.E., and Ohrvik J. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis Circulation 98 1998 2520 2526
23. Dankner R., Chetrit A., and Ken Dror G. Physical activity is inversely associated to homocysteine levels, independent of C677T MTHFR genotype and plasma B-vitamins AGE 29 2007 219 227
24. Modan M., Halkin H., and Almog S. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance J Clin Invest 75 1985 809 817
25. Höybye C., Bruun J.M., and Richelsen B. Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment Eur J Endocrinol 151 2004 457 461
26. Frystyk J., Tarnow L., and Hansen T.K. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications Diabetologia 48 2005 1911 1918 (Pubitemid 41317848)
27. Andersen K.K., Frystyk J., and Wolthers O.D. Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children J Clin Endocrinol Metab 92 2007 1857 1862
28. Jacobsen D.W., Gatautis V.J., and Green R. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects Clin Chem 40 1994 873 881
29. Bonsnes R.W., and Taussky H.H. On the colorimetric determination of creatinine by the Jaffe reaction J Biol Chem 158 1945 581 591
30. Jurinke C., Denissenko M.F., and Oeth P. A single nucleotide polymorphism based approach for the identification and characterization of gene expression modulation using MassARRAY (review) Mutat Res 573 2005 83 95
31. Dzielinska Z., Januszewica A., and Wiecek A. Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease Thromb Res 110 2003 365 369
32. Sakuta H., Suzuki T., and Yasuda H. Adiponectin levels and cardiovascular risk factors in Japanese men with type 2 diabetes Endocr J 52 2005 241 244
33. Altinova A.E., Toruner F., and Bukan N. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects Endocr J 54 2007 221 226
34. Jacques P.F., Bostom A.G., and Wilson P.W.F. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort Am J Clin Nutr 73 2001 613 621
35. Nishizawa H., Shimomura I., and Kishida K. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein Diabetes 51 2002 2734 2741
36. Adamczak M., Rzepka E., and Chudek J. Ageing and plasma adiponectin concentration in apparently healthy males and females Clin Endocrinol 62 2005 114 118
37. Sattar N., and Nelson S.M. Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox J Clin Endocrinol Metab 93 2008 3299 3301
38. Prior S.L., Tang T.S., Gill G.V., Bain S.C., and Stephens J.W. Adiponectin, total antioxidant status, and urind albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort Metabolism 2010 [Epub ahead of print]
39. Aso Y., Yamamota R., and Wakabayashi S. Comparison of serum high-molecular weight (HMW) with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin Diabetes 55 2006 1954 1960
40. Saraheimo M., Forsblom C., and Thorn L. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes Diabetes Care 31 2008 1165 1169
41. Isobe T., Saitoh S., and Takagi S. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study Eur J Endocrinol 153 2005 91 98
42. Tentolouris N., Doulgerakis D., and Moyssakis I. Plasma adiponectin concentrations in patients with chronic renal failure. Relationship with metabolic risk factors and ischemic heart disease Horm Metab Res. 36 2004 721 727
43. Schalkwijk C.G., Chaturvedi N., and Schram M.T. Adiponectin is inversely associated with renal function in type 1 diabetic patients J Clin Endocrinol Metab 91 2006 129 135
44. Yoshioka M., Boivin A., and Bolduc C. Gender difference of androgen actions on skeletal muscle transcriptome J Mol Endocrinol 39 2007 119 133
45. Krause M.P., Liu Y., and Vu V. Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function Am J Physiol Cell Physiol 295 2008 C203 C212
46. Gallagher D., Ruts E., and Visser M. Weight stability masks sarcopenia in elderly men and women Am J Physiol Endocrinol Metab 279 2000 E366 E375
47. Cnop M., Havel P.J., and Utschneider K.M. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46 2003 459 469
48. Tanko L.B., Bruun J.M., and Alexandersen P. Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis Circulation 110 2004 2246 2252
49. Leth H., Andersen K.K., and Frystyk J.H. Elevated levels of high-molecular-weight adiponectin in type 1 diabetes J Clin Endocrinol Metab 93 2008 3186 3191
50. von Eynatten M., Humpert P.M., and Bluemm A. High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men Atherosclerosis 199 2008 123 128
51. Tabara Y., Osawa H., and Kawamoto R. Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study J Clin Endocrinol Metab 93 2008 715 722
52. Xu A., Chan K.W., and Hoo R.L.C. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes J Biol Chem 280 2005 18073 18080
53. Empana J.P. Adiponectin isoforms and cardiovascular disease Eur Heart J 29 2008 1221 1223